Long noncoding RNA regulation of adaptive immunity
Long noncoding RNA regulation of adaptive immunity
Disciplines
Biology (20%); Medical-Theoretical Sciences, Pharmacy (80%)
Keywords
-
Long Noncoding Rna,
Knockout Mouse Model,
Memory Cd8 T Cell,
CD8 T cell differentiation
The decoding of the human genome in 2001 revealed that humans have about 20,000 genes that are responsible for the production of proteins. Genes are precisely defined sections of DNA that are rewritten in RNA to produce proteins. Amazingly, less complex organisms like the 1 mm long roundworm C. elegans have as many genes as humans. This discrepancy between the number of genes and biological complexity can probably be explained by the fact that the 20,000 protein-coding genes represent only 2% of the entire human genome. However, the human body produces a much larger number of RNA molecules that are not used for protein production. These so-called noncoding RNA molecules increase in the genome of complex organisms and play an important role in regulating gene expression. Non- coding RNA is often referred to as the "dark matter" of the genome, since its biological relevance is mostly unknown. In preliminary results, our research group was able to show that non-coding RNA molecules play an important role in the immune system. Our research project therefore focuses on the identification and biological relevance of non-coding RNA molecules in immune cells, which are responsible for the successful defense against viruses, bacteria and tumor cells. Our research study aims to enhance our understanding of the regulation of immune cells. Our results could therefore identify new approaches for improving cancer immunotherapies.
- Christoph Bock, CeMM – Forschungszentrum für Molekulare Medizin GmbH , national collaboration partner
- Kikue Tachibana, IMBA – Institut für Molekulare Biotechnologie GmbH , national collaboration partner
- Andreas Spittler, Medizinische Universität Wien , national collaboration partner
- Gerald Timelthaler, Medizinische Universität Wien , national collaboration partner
- Lukas Kenner, Medizinische Universität Wien , national collaboration partner
- Martin Filipits, Medizinische Universität Wien , national collaboration partner
- Martin Holcmann, Medizinische Universität Wien , national collaboration partner
Research Output
- 3 Citations
- 1 Publications
- 1 Disseminations
- 3 Fundings
-
2023
Title Regulation of T cell differentiation and function by long noncoding RNAs in homeostasis and cancer DOI 10.3389/fimmu.2023.1181499 Type Journal Article Author Erber J Journal Frontiers in Immunology Pages 1181499 Link Publication
-
2024
Title Functional heterogeneity of mesenchymal stromal cells Type Research grant (including intramural programme) DOI 10.55776/p36995 Start of Funding 2024 Funder Austrian Science Fund (FWF) -
2021
Title Innate immune reprogramming to overcome therapy resistance in high-risk colorectal cancer Type Research grant (including intramural programme) DOI 10.47379/ls20042 Start of Funding 2021 Funder Vienna Science and Technology Fund -
2024
Title Travel Grant for European Congress of Immunology 2024 for Julia Erber Type Travel/small personal Start of Funding 2024 Funder European Federation of Immunological Societies (EFIS)